Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-03 · accession 0001062993-21-010282 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-04 | 2021-11-03 | ACH | Pace Nicholas J | EVP GC, CorpSec | S - Sale | $42.40 | -49.4K | 223.7K | -18% | -$2.09M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-03 | S | D | 5,267 | $41.42 | 197,158 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F9) Weighted average of the sale price range of $41.12 through $42.10 |
| 2 | Common | Common Stock | 2021-11-03 | S | D | 2,400 | $42.59 | 194,758 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F10) Weighted average of the sale price range of $42.20 through $42.98 |
| 3 | Common | Common Stock | 2021-11-03 | S | D | 600 | $43.85 | 194,158 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F11) Weighted average of the sale price range of $43.43 through $44.16 |
| 4 | Common | Common Stock | 2021-11-03 | S | D | 643 | $45.16 | 193,515 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F12) Weighted average of the sale price range of $44.50 through $45.43 |
| 5 | Common | Common Stock | 2021-11-03 | S | D | 100 | $45.50 | 193,415 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. |
| 6 | Common | Common Stock | 2021-11-03 | S | D | 1,900 | $45.41 | 202,425 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F8) Weighted average of the sale price range of $45.31 through $45.62 |
| 7 | Common | Common Stock | 2021-11-03 | S | D | 2,394 | $44.94 | 204,325 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F7) Weighted average of the sale price range of $44.30 through $45.30 |
| 8 | Common | Common Stock | 2021-11-03 | S | D | 3,318 | $43.83 | 206,719 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F6) Weighted average of the sale price range of $43.23 through $44.18 |
| 9 | Common | Common Stock | 2021-11-03 | S | D | 13,639 | $42.61 | 210,037 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F5) Weighted average of the sale price range of $42.15 through $43.08 |
| 10 | Common | Common Stock | 2021-11-03 | S | D | 1,153 | $40.75 | 241,632 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F2) Weighted average of the sale price range of $40.15 through $41.12 (F3) Balance includes employee stock purchase plan holdings not previously reflected in beneficial ownership total. |
| 11 | Common | Common Stock | 2021-11-03 | S | D | 17,956 | $41.51 | 223,676 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F4) Weighted average of the sale price range of $41.15 through $42.10 |